Synapsoft logo
AI Insights from Disclosures
Searching...
HLB Genex, Inc. 187420
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
HLB Genex, Inc. develops and produces customized enzymes and biohealthcare materials, and develops microbiome-based new drugs. Since its founding on April 1, 2000 as a spin-off of the Korea Research Institute of Bioscience and Biotechnology, the company has secured its core technologies: (1) microbial display technology for rapidly and accurately improving enzymes, and (2) recombinant protein secretion and expression technology for economically mass-producing enzymes.
Representative Director 김의중, 김도연 (각자 대표이사)
Founded March 29, 2000
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 16011-0095821
Business number 314-81-32185
Phone Number 042-862-4483
Fax Number 042-862-4484
Company Address 65 Techno 1-ro, Yuseong-gu, Daejeon
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant